C21 Investments Inc. (CXXIF) will release its second‑quarter 2025 financial results on Tuesday, November 11, 2025, before the market opens.
The company is a vertically integrated cannabis operator listed on the OTCQX and CSE, and it has been pursuing a strategy of growth and operational efficiency across its retail, wholesale, and cultivation segments.
In the prior quarter, C21 reported revenue of $7.5 million for Q2 2024, a 14% sequential increase, and a gross margin of 43.5%—up from 40.0% in the same quarter a year earlier and from 30.8% in Q1 2024—reflecting gains from new dispensary openings and improved cost control.
Segment performance in Q2 2024 showed that retail sales grew 18% year‑over‑year, driven by the launch of a new store in South Reno, while wholesale volumes remained flat. The company’s cultivation operations continued to expand capacity, supporting the retail growth and contributing to margin improvement.
CEO Sonny Newman highlighted that the company’s focus on scaling operations and tightening cost structures has positioned it to capture market share in a competitive cannabis market. He emphasized that the upcoming earnings release will provide a clearer view of how these initiatives are translating into financial results.
Analysts have assigned a consensus “Hold” rating to CXXIF, with no buy or sell recommendations reported in the latest coverage. The rating reflects the company’s ongoing efforts to strengthen its financial position amid a challenging industry environment.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.